{"title": "nfluenza A (H1N1) 2009 Monovalent Vaccine (ID Biomedical Corp)", "author": "Center; Research", "url": "https://www.fda.gov/vaccines-blood-biologics/vaccines/influenza-h1n1-2009-monovalent-vaccine-id-biomedical-corporation-quebec", "hostname": "fda.gov", "description": "Active immunization of persons ages 18 years of age older against influenza disease caused by pandemic (H1N1) 2009 virus", "sitename": "FDA", "date": "2022-11-15", "cleaned_text": "Influenza A (H1N1) 2009 Monovalent Vaccine (ID Biomedical Corporation of Quebec) STN: 125163 Proper Name: Influenza A (H1N1) 2009 Monovalent Vaccine Tradename: None Manufacturer: ID Biomedical Corporation of Quebec Indication: Active immunization of persons ages 18 years of age older against influenza disease caused by pandemic (H1N1) 2009 virus. Product Information Supporting Documents [Supporting Documents older than three years -Influenza A (H1N1) 2009 Monovalent Vaccine (ID Biomedical Corporation of Quebec)](http://wayback.archive-it.org/7993/20171114160753/https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm189907.htm) Related Information [Influenza A (H1N1) 2009 Monovalent](/vaccines-blood-biologics/vaccines/influenza-h1n1-2009-monovalent) Answers](/vaccines-blood-biologics/vaccines/influenza-h1n1-2009-monovalent-vaccines-questions-and-answers) (H1N1) Monovalent Composition and Lot Release](/vaccines-blood-biologics/lot-release/influenza-h1n1-2009-monovalent-vaccines-composition-and-lot-release) [Influenza A 2009 Monovalent Vaccine Safety "}